M. A. Reinhardt

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
PURPOSE Nonsurgical treatment of lymphangiomas has shown limited efficacy and often carries unacceptable toxicities, demonstrating the need for a more effective, less toxic therapy. PATIENTS AND METHODS We describe two patients with lymphangiomatosis treated for 12 to 40 months with recombinant interferon-alpha. RESULTS Both patients demonstrated(More)
Although there are indications that flap viability depends on venous outflow, only few publications deal with this subject. The studies that have been published refer only to macroscopic flap necrosis. We investigated various venous situations following free tissue transfer under baseline conditions and after moderate (1 h) and severe (8 h) secondary(More)
  • 1